According to NeoGenomics
's latest financial reports the company's current revenue (TTM ) is $0.67 Billion USD. In 2024 the company made a revenue of $0.66 Billion USD an increase over the revenue in the year 2023 that were of $0.59 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | $0.67 B | 1.79% |
2024 | $0.66 B | 11.65% |
2023 | $0.59 B | 16.07% |
2022 | $0.50 B | 5.24% |
2021 | $0.48 B | 8.97% |
2020 | $0.44 B | 8.71% |
2019 | $0.40 B | 47.73% |
2018 | $0.27 B | 12.21% |
2017 | $0.24 B | 1.04% |
2016 | $0.24 B | 144.57% |
2015 | $99.8 M | 14.62% |
2014 | $87.06 M | 30.99% |
2013 | $66.46 M | 11.02% |
2012 | $59.86 M | 37.68% |
2011 | $43.48 M | 26.51% |
2010 | $34.37 M | 16.63% |
2009 | $29.46 M | 47.23% |
2008 | $20.01 M | 73.97% |
2007 | $11.5 M | 77.65% |
2006 | $6.47 M | 243.5% |
2005 | $1.88 M | 237.83% |
2004 | $0.55 M | 50.84% |
2003 | $0.36 M | |
2000 | $0.25 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() RadNet RDNT | $1.86 B | 178.03% | ๐บ๐ธ USA |
![]() Psychemedics PMD | $19.68 M | -97.07% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $10.15 B | 1,410.80% | ๐บ๐ธ USA |
![]() LabCorp LH | $13.17 B | 1,859.87% | ๐บ๐ธ USA |
![]() Enzo Biochem ENZB | $27.47 M | -95.91% | ๐บ๐ธ USA |